C8R-31883-66755
4 vaccinations
2 coded responses
28 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 982 / WA
- Registered
- 2021-01-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
CCJ-38457-88676
Child or adolescent in my care · Male · 2022-06-22
Timeline
-
2021-01-06
Registered in v-safe
-
2021-01-06
Dose 1 — Pfizer-BioNTech
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-12
- 2021-01-14
- 2021-01-20
-
2021-01-29
Dose 2 — Pfizer-BioNTech
- 2021-01-29
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-04
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-02-26
-
2021-03-05
Survey response — day 35, dose 2MedDRA: Postpartum disorder, Pre-eclampsia — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Postpartum pre-eclampsia at 6 days post partumMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-05
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-14
- 2021-03-14
- 2021-04-30
-
2021-10-04
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2022-01-31
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-10-25
Dose 4 — Pfizer-BioNTech
- 2022-11-01
- 2022-11-10
- 2022-11-24
- 2022-11-29
- 2022-12-06
- 2023-04-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Pfizer-BioNTech | |
| 2 | 2021-01-29 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | Flu |
| 4 | 2022-10-25 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 5 — day 35, dose 2
Symptoms: Postpartum pre-eclampsia at 6 days post partum
Release 11 — 12 months, dose 2
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Postpartum disorder | ✓ | ✓ | ✓ |
| SD | Pre-eclampsia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release